Delivery Order SPE2DB22D2206-SPE2DB24FHB99
Award Date
5/8/24
Potential Completion Date
5/9/24
Potential Value
$42K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bupropion HCL XL 300mg tablets. The contract has a ceiling value of $11,557.69 and a period of performance through April 24, 2024. It is a Firm Fixed Price contract, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of BUPROPION HCL XL 300 MG TABLET 500S, with a potential value of $1,635.40 and a performance period through January 31, 2024. This order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Bupropion HCL XL 300 mg tablets. The contract has a fixed-price, firm-fixed-price structure and a ceiling value of $56,117.46. The ultimate completion date is May 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide 500 units of BUPROPION HCL XL 300 MG TABLET. The contract has a total potential value of $5,376.14 and a completion date of February 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,268.05, is for the delivery of bupropion HCL XL 150 mg tablets in 500-count packages. The contract is a firm fixed-price delivery order with a period of performance ending on March 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BUPROPION HCL XL 300 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $105,516.75 and a performance period ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,928 bupropion HCL XL 300 mg tablets in 500-count bottles. The $2,160 contract has an ultimate completion date of April 12, 2024 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, the prime contractor, is the sole awardee on this delivery order, which is issued against a...
The U.S. Defense Logistics Agency (DLA) awarded a $31,697.41 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,154,812 units of bupropion HCL XL 300 mg tablets. The contract has an ultimate completion date of December 21, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary...
The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 500 count bupropion HCl XL 150 mg tablets. The contract has a ceiling value of $8,419.32 and a performance period through March 13, 2024. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical, with a potential...